Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England
Open Access
- 1 August 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet Public Health
- Vol. 2 (8), e367-e374
- https://doi.org/10.1016/s2468-2667(17)30103-2
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- The Relationship Between Respiratory Syncytial Virus and AsthmaVeterinary Pathology, 2014
- The role of health economic analyses in vaccine decision makingVaccine, 2013
- Respiratory Syncytial Virus–Associated Hospitalizations Among Children Less Than 24 Months of AgePEDIATRICS, 2013
- Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The NetherlandsVaccine, 2012
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Confounding by Season in Ecologic Studies of Seasonal Exposures and Outcomes: Examples From Estimates of Mortality Due to InfluenzaAnnals of Epidemiology, 2009
- The Need for Validation of Statistical Methods for Estimating Respiratory Virus-Attributable HospitalizationAmerican Journal of Epidemiology, 2009
- The Burden of Respiratory Syncytial Virus Infection in Young ChildrenThe New England Journal of Medicine, 2009
- Evaluating rotavirus vaccination in England and Wales: Part I. Estimating the burden of diseaseVaccine, 2007
- Respiratory Syncytial Virus Infection in AdultsClinical Microbiology Reviews, 2000